OTCMKTS:DSRLF DiaSorin (DSRLF) Stock Forecast, Price & News $104.50 0.00 (0.00%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$104.50▼$104.5050-Day Range$104.50▼$120.0052-Week Range$104.50▼$147.15VolumeN/AAverage Volume1 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$143.00 ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About DiaSorin (OTCMKTS:DSRLF) StockDiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. The firm specializes in the immunodiagnostics and molecular diagnostics segments. It provides clinical services in the areas like Infectious Diseases, Bone and Mineral, Endocrinology, Hypertension, Oncology, Stool Diagnostics and Autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.Read More Receive DSRLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter. Email Address DSRLF Stock News HeadlinesMay 28, 2023 | americanbankingnews.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Given Consensus Recommendation of "Reduce" by BrokeragesMay 9, 2023 | msn.comDiaSorin confirms 2023 guidance after Q1 resultsJune 9, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.May 1, 2023 | americanbankingnews.comBrokerages Set DiaSorin S.p.A. (OTCMKTS:DSRLF) PT at $144.00April 15, 2023 | americanbankingnews.comDiaSorin (OTCMKTS:DSRLF) vs. Bankinter (OTCMKTS:BKNIY) Head to Head SurveyApril 8, 2023 | americanbankingnews.comBrokerages Set DiaSorin S.p.A. (OTCMKTS:DSRLF) Price Target at $144.00April 6, 2023 | barrons.comDiaSorin S.p.A.April 6, 2023 | americanbankingnews.comDiaSorin (OTCMKTS:DSRLF) Downgraded by Kepler Capital MarketsJune 9, 2023 | PressReach (Ad)This Stock's Worth ResearchingUncover the buzz behind this trending stock. Read the comprehensive report here.April 4, 2023 | americanbankingnews.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Significant Growth in Short InterestApril 1, 2023 | americanbankingnews.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Expected to Earn Q1 2023 Earnings of $1.00 Per ShareMarch 31, 2023 | americanbankingnews.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Forecasted to Earn FY2023 Earnings of $4.13 Per ShareMarch 29, 2023 | seekingalpha.comDiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call TranscriptMarch 4, 2023 | seekingalpha.comDiaSorin: Overvalued Italian Healthcare CompanyFebruary 15, 2023 | wsj.comCytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinFebruary 13, 2023 | finance.yahoo.comCytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinOctober 31, 2022 | reuters.comDIAS.MI - DiaSorin SpA | Stock Price & Latest News | ReutersAugust 8, 2022 | seekingalpha.comDiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call TranscriptOctober 23, 2021 | finance.yahoo.comSouthwest Airlines Company (LUV) stock forecast and price targetAugust 2, 2021 | seekingalpha.comDiaSorin S.p.A. 2021 Q2 - Results - Earnings Call PresentationApril 21, 2021 | businesswire.comQIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early ...April 13, 2021 | finance.yahoo.comLuminex (LMNX) to Get Acquired by DiaSorin for Around $1.8BApril 12, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Luminex Corporation BuyoutApril 12, 2021 | markets.businessinsider.comDiaSorin To Buy Luminex For $1.8 BlnApril 12, 2021 | finance.yahoo.comShareholder Alert: Ademi LLP investigates whether Luminex Corporation has obtained a Fair Price in its transaction with DiaSorinApril 12, 2021 | investing.comLuminex Jumps on $1.8 Billion Deal from Italy’s DiaSorinApril 12, 2021 | msn.comLuminex Jumps on $1.8 Billion Pact to Be Bought by DiaSorinSee More Headlines DSRLF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DSRLF Company Calendar Today6/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:DSRLF CUSIPN/A CIKN/A Webwww.diasoringroup.com Phone391614871FaxN/AEmployees3,358Year FoundedN/APrice Target and Rating Average Stock Price Forecast$143.00 High Stock Price Forecast$153.00 Low Stock Price Forecast$135.00 Forecasted Upside/Downside+36.8%Consensus RatingHold Rating Score (0-4)1.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.46 billion Price / SalesN/A Cash Flow$9.79 per share Price / Cash Flow10.67 Book Value$29.58 per share Price / Book3.53Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.45 Key ExecutivesCarlo RosaChief Executive Officer, Executive Director & GMRiccardo PalmisanoCEOPiergiorgio PedronGroup Chief Financial Officer & Senior VPChen Menachem EvenExecutive Director & Chief Commercial OfficerRiccardo FavaVice President-Investor Relations & CommunicationsKey CompetitorsMDxHealthOTCMKTS:MXDHFRecordati Industria Chimica e FarmaceuticaOTCMKTS:RCDTFRespiriOTCMKTS:KMLXFSunny Optical Technology (Group)OTCMKTS:SNPTF[email protected] TechnologyOTCMKTS:LPTCView All Competitors DSRLF Stock - Frequently Asked Questions Should I buy or sell DiaSorin stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" DSRLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DSRLF, but not buy additional shares or sell existing shares. View DSRLF analyst ratings or view top-rated stocks. What is DiaSorin's stock price forecast for 2023? 6 brokerages have issued 12-month target prices for DiaSorin's shares. Their DSRLF share price forecasts range from $135.00 to $153.00. On average, they anticipate the company's share price to reach $143.00 in the next twelve months. This suggests a possible upside of 36.8% from the stock's current price. View analysts price targets for DSRLF or view top-rated stocks among Wall Street analysts. How have DSRLF shares performed in 2023? DiaSorin's stock was trading at $147.15 at the beginning of 2023. Since then, DSRLF stock has decreased by 29.0% and is now trading at $104.50. View the best growth stocks for 2023 here. Are investors shorting DiaSorin? DiaSorin saw a increase in short interest in May. As of May 15th, there was short interest totaling 285,000 shares, an increase of 28.8% from the April 30th total of 221,300 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 2,850.0 days. View DiaSorin's Short Interest. What is DiaSorin's stock symbol? DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF." How do I buy shares of DiaSorin? Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is DiaSorin's stock price today? One share of DSRLF stock can currently be purchased for approximately $104.50. How many employees does DiaSorin have? The company employs 3,358 workers across the globe. How can I contact DiaSorin? DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The official website for the company is www.diasoringroup.com. The company can be reached via phone at 391614871 or via email at ines.diterlizzi@diasorin.it. This page (OTCMKTS:DSRLF) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaSorin S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.